Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Circulating tumor cells as a treatment monitoring tool in metastatic breast cancer

Wolfgang Janni • 14 Dec 2020
SABCS 2020
Breast Cancer

Wolfgang Janni, MD, PhD, Ulm University, Ulm, Germany, outlines the clinical utility of repeated circulating tumor cell enumeration as an early treatment monitoring tool in metastatic breast cancer as evaluated in a global, pooled analysis of individual patient data. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Wolfgang Janni

1:46
SUCCESS-A trial: ctDNA screening's potential in early-stage breast cancer recurrence prediction
Wolfgang Janni • 5 Dec 2023
1:37
SURVIVE study: liquid biopsy guided follow-up surveillance in early breast cancer
Wolfgang Janni • 5 Dec 2023
1:36
ctDNA assay for detection of recurrent disease in patients with early-stage breast cancer
Wolfgang Janni • 22 Sep 2021
1:19
MONALEESA-2: improved OS seen in HR+ advanced breast cancer treated with ribociclib + letrozole
Wolfgang Janni • 22 Sep 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals